Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Waters

Showing results (121-130 of 157) with videos related to

Pageof 16
Sort By:
Circulation|March 31, 2012
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) studySamia Mora, Nanette K Wenger, David A Demicco, et al.
Circulation|September 25, 2002
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudyDavid D Waters, Gregory G Schwartz, Anders G Olsson, et al.
European Journal of Clinical Investigation|September 28, 2010
On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets studyBas van den Bogaard, Bert-Jan H van den Born, Rana Fayyad, et al.
Circulation|January 5, 2002
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery diseaseSatyendra Giri, Leslee J Shaw, Dakshina R Murthy, et al.
Lancet (London, England)|September 12, 2006
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets studyPrakash Deedwania, Philip Barter, Rafael Carmena, et al.
AIDS (London, England)|November 23, 2006
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responsesPriscilla Y Hsue, Peter W Hunt, Elizabeth Sinclair, et al.
Circulation|June 24, 2009
Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goalsDavid D Waters, Carlos Brotons, Cheng-Wen Chiang, et al.
Circulation|February 19, 2004
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trialsDavid D Waters, David Gordon, Jacques E Rossouw, et al.
The New England Journal of Medicine|March 10, 2005
Intensive lipid lowering with atorvastatin in patients with stable coronary diseaseJohn C LaRosa, Scott M Grundy, David D Waters, et al.
The American Journal of Cardiology|December 16, 2011
Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calciumPriscilla Y Hsue, Karen Ordovas, Theodore Lee, et al.
Pageof 16

Showing results (121-130 of 157) with videos related to

Sort By:
Pageof 16
Circulation|March 31, 2012
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) studySamia Mora, Nanette K Wenger, David A Demicco, et al.
Circulation|September 25, 2002
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudyDavid D Waters, Gregory G Schwartz, Anders G Olsson, et al.
European Journal of Clinical Investigation|September 28, 2010
On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets studyBas van den Bogaard, Bert-Jan H van den Born, Rana Fayyad, et al.
Circulation|January 5, 2002
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery diseaseSatyendra Giri, Leslee J Shaw, Dakshina R Murthy, et al.
Lancet (London, England)|September 12, 2006
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets studyPrakash Deedwania, Philip Barter, Rafael Carmena, et al.
AIDS (London, England)|November 23, 2006
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responsesPriscilla Y Hsue, Peter W Hunt, Elizabeth Sinclair, et al.
Circulation|June 24, 2009
Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goalsDavid D Waters, Carlos Brotons, Cheng-Wen Chiang, et al.
Circulation|February 19, 2004
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trialsDavid D Waters, David Gordon, Jacques E Rossouw, et al.
The New England Journal of Medicine|March 10, 2005
Intensive lipid lowering with atorvastatin in patients with stable coronary diseaseJohn C LaRosa, Scott M Grundy, David D Waters, et al.
The American Journal of Cardiology|December 16, 2011
Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calciumPriscilla Y Hsue, Karen Ordovas, Theodore Lee, et al.
Pageof 16